NWAMX
Price
$33.06
Change
+$0.43 (+1.32%)
Updated
Dec 20 closing price
RMFCX
Price
$54.73
Change
+$0.55 (+1.02%)
Updated
Dec 20 closing price
Ad is loading...

NWAMX vs RMFCX

Header iconNWAMX vs RMFCX Comparison
Open Charts NWAMX vs RMFCXBanner chart's image
Nationwide BNY Mellon Dyn US Eq Inc K
Price$33.06
Change+$0.43 (+1.32%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.73
Change+$0.55 (+1.02%)
VolumeN/A
CapitalizationN/A
NWAMX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NWAMX vs. RMFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWAMX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. NWAMX (609M). RMFCX (1.69) and NWAMX (1.62) have matching dividends . NWAMX was incepted earlier than RMFCX: NWAMX (37 years) vs RMFCX (23 years). NWAMX is a more actively managed with annual turnover of: 76.61 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than NWAMX: RMFCX (250) vs NWAMX (2500). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. NWAMX (1.06). RMFCX return over 5 years is better than : 37.80 vs. NWAMX (3.33).
NWAMXRMFCXNWAMX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years23 years-
Gain YTD0.2159.9212%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets609M102B1%
Annual Yield % from dividends1.621.6995%
Returns for 1 year1.0611.1110%
Returns for 3 years-1.1412.38-9%
Returns for 5 years3.3337.809%
Returns for 10 years1.3759.362%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA